IP-R Stock Overview
Manufactures, imports, and distributes dietary supplement products for humans and animals in Thailand.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Inter Pharma Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿5.00 |
| 52 Week High | ฿7.88 |
| 52 Week Low | ฿4.66 |
| Beta | 0.51 |
| 11 Month Change | -16.67% |
| 3 Month Change | -11.68% |
| 1 Year Change | -31.72% |
| 33 Year Change | -60.17% |
| 5 Year Change | n/a |
| Change since IPO | 26.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| IP-R | TH Personal Products | TH Market | |
|---|---|---|---|
| 7D | -1.0% | 1.6% | -0.02% |
| 1Y | -31.7% | -0.3% | -13.4% |
Return vs Industry: IP-R underperformed the TH Personal Products industry which returned -0.3% over the past year.
Return vs Market: IP-R underperformed the TH Market which returned -13.4% over the past year.
Price Volatility
| IP-R volatility | |
|---|---|
| IP-R Average Weekly Movement | 6.1% |
| Personal Products Industry Average Movement | 6.1% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in TH Market | 8.6% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: IP-R's share price has been volatile over the past 3 months.
Volatility Over Time: IP-R's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Trinnawat Thanitnithiphan | www.interpharma.co.th |
Inter Pharma Public Company Limited manufactures, imports, and distributes dietary supplement products for humans and animals in Thailand. It operates through three: Human Healthcare, Animal Healthcare, and Hospital segments. The company offers human, anti-aging, and human products, such as medical supplies, nutrition therapy, cosmetics, supplementary foods, probiotic and prebiotic products, health food products, general food products, medical equipment and medicines, etc.; functional foods and drinks; and pharmaceutical products; It also provides pet healthcare and livestock products comprising medical supplies, nutrition therapy, vaccines, supplementary foods, probiotic and prebiotic products, animal health food products, premium grade animal foods, general formula animal foods, medical equipment related to pet and livestock care product, etc. In addition, the company provides care and treatment for patients with general and specialized diseases, such as cardiovascular disease, bone and joint disease, neuropathy, medical diseases, surgical diseases, kidney disease, obstetrics and gynecology, ear, eye, nose, throat diseases, blood diseases, pediatric clinics, etc. Further, it offers nutraceuticals, ear and teeth cleaners, pee pads, shampoos, and cosmeceuticals products.
Inter Pharma Public Company Limited Fundamentals Summary
| IP-R fundamental statistics | |
|---|---|
| Market cap | ฿3.03b |
| Earnings (TTM) | ฿27.42m |
| Revenue (TTM) | ฿1.81b |
110.4x
P/E Ratio1.7x
P/S RatioIs IP-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IP-R income statement (TTM) | |
|---|---|
| Revenue | ฿1.81b |
| Cost of Revenue | ฿1.14b |
| Gross Profit | ฿670.33m |
| Other Expenses | ฿642.91m |
| Earnings | ฿27.42m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.045 |
| Gross Margin | 37.06% |
| Net Profit Margin | 1.52% |
| Debt/Equity Ratio | 13.7% |
How did IP-R perform over the long term?
See historical performance and comparison